Clinical Trials

NCT03816345 | RECRUITING | PHASE1
300 participants

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2019-07-16
Completion:
2028-03-30
Conditions
  • Autoimmune Disease
  • Crohn Disease
  • Dermatomyositis
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Inflammatory Bowel Disease
  • Malignant Solid Neoplasm
  • Multiple Sclerosis
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Sjogren Syndrome
  • Systemic Lupus Erythematosus
  • Systemic Scleroderma
  • Ulcerative Colitis
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT03808610 | TERMINATED | PHASE1/PHASE2
53 participants

Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2019-04-03
Completion:
2026-05-05
Conditions
  • Recurrent B Acute Lymphoblastic Leukemia
  • Recurrent T Acute Lymphoblastic Leukemia
  • Refractory B Acute Lymphoblastic Leukemia
  • Refractory T Acute Lymphoblastic Leukemia
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT03375307 | SUSPENDED | PHASE2
60 participants

Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2020-11-03
Completion:
2026-12-16
Conditions
  • Advanced Bladder Carcinoma
  • Advanced Genitourinary System Carcinoma
  • Metastatic Bladder Carcinoma
  • Metastatic Genitourinary System Carcinoma
  • Stage III Bladder Cancer AJCC v8
  • Stage IV Bladder Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT03321643 | ACTIVE_NOT_RECRUITING | PHASE1
24 participants

Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2018-09-18
Completion:
2026-06-30
Conditions
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Transformed Non-Hodgkin Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Transformed Non-Hodgkin Lymphoma
  • Richter Syndrome
  • Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT03304639 | COMPLETED | PHASE2
9 participants

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2018-06-12
Completion:
2022-06-07
Conditions
  • Advanced Merkel Cell Carcinoma
  • Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
  • Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8
  • Metastatic Merkel Cell Carcinoma
  • Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
  • Pathologic Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v8
  • Pathologic Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v8
  • Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8
Interventions
  • BIOLOGICAL
  • RADIATION
NCT03237780 | ACTIVE_NOT_RECRUITING | PHASE2
72 participants

Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-13
Start Date:
2018-07-20
Completion:
2027-06-30
Conditions
  • Locally Advanced Bladder Urothelial Carcinoma
  • Locally Advanced Renal Pelvis Urothelial Carcinoma
  • Locally Advanced Ureter Urothelial Carcinoma
  • Locally Advanced Urethral Urothelial Carcinoma
  • Metastatic Bladder Urothelial Carcinoma
  • Metastatic Renal Pelvis Urothelial Carcinoma
  • Metastatic Ureter Urothelial Carcinoma
  • Metastatic Urethral Urothelial Carcinoma
  • Recurrent Bladder Urothelial Carcinoma
  • Recurrent Renal Pelvis Urothelial Carcinoma
  • Recurrent Ureter Urothelial Carcinoma
  • Recurrent Urethral Urothelial Carcinoma
  • Stage III Bladder Cancer AJCC v8
  • Stage III Renal Pelvis Cancer AJCC v8
  • Stage III Ureter Cancer AJCC v8
  • Stage III Urethral Cancer AJCC v8
  • Stage IV Bladder Cancer AJCC v8
  • Stage IV Renal Pelvis Cancer AJCC v8
  • Stage IV Ureter Cancer AJCC v8
  • Stage IV Urethral Cancer AJCC v8
  • Unresectable Bladder Urothelial Carcinoma
  • Unresectable Renal Pelvis Urothelial Carcinoma
  • Unresectable Ureter Urothelial Carcinoma
  • Unresectable Urethral Urothelial Carcinoma
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page